Prudential Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $993K | Buy |
50,693
+3,490
| +7% | +$85.4K | ﹤0.01% | 1604 |
|
|
2025
Q4 | $1.26M | Sell |
47,203
-226
| -0.5% | -$5.82K | ﹤0.01% | 1518 |
|
|
2025
Q3 | $1.26M | Buy |
47,429
+5,478
| +13% | +$141K | ﹤0.01% | 1570 |
|
|
2025
Q2 | $1.75M | Buy |
41,951
+4,337
| +12% | +$108K | ﹤0.01% | 1446 |
|
|
2025
Q1 | $1.67M | Sell |
37,614
-1,080
| -3% | -$34.5K | ﹤0.01% | 1360 |
|
|
2024
Q4 | $1.73M | Sell |
38,694
-630
| -2% | -$28.8K | ﹤0.01% | 1364 |
|
|
2024
Q3 | $1.91M | Sell |
39,324
-2,101
| -5% | -$92.2K | ﹤0.01% | 1530 |
|
|
2024
Q2 | $1.66M | Sell |
41,425
-559
| -1% | -$23.2K | ﹤0.01% | 1532 |
|
|
2024
Q1 | $1.84M | Sell |
41,984
-1,025
| -2% | -$52.9K | ﹤0.01% | 1500 |
|
|
2023
Q4 | $2.66M | Sell |
43,009
-1,596
| -4% | -$83.8K | ﹤0.01% | 1259 |
|
|
2023
Q3 | $2.05M | Sell |
44,605
-1,903
| -4% | -$104K | ﹤0.01% | 1350 |
|
|
2023
Q2 | $2.67M | Buy |
46,508
+9,391
| +25% | +$416K | ﹤0.01% | 1230 |
|
|
2023
Q1 | $1.39M | Sell |
37,117
-69,616
| -65% | -$2.28M | ﹤0.01% | 1561 |
|
|
2022
Q4 | $2.99M | Sell |
106,733
-34,399
| -24% | -$999K | 0.01% | 1112 |
|
|
2022
Q3 | $3.97M | Buy |
141,132
+51,117
| +57% | +$1.67M | 0.01% | 959 |
|
|
2022
Q2 | $3.07M | Buy |
90,015
+9,130
| +11% | +$326K | ﹤0.01% | 1141 |
|
|
2022
Q1 | $2.9M | Sell |
80,885
-24,020
| -23% | -$681K | ﹤0.01% | 1284 |
|
|
2021
Q4 | $2.44M | Sell |
104,905
-21,747
| -17% | -$445K | ﹤0.01% | 1415 |
|
|
2021
Q3 | $2.41M | Sell |
126,652
-55,013
| -30% | -$1.08M | ﹤0.01% | 1354 |
|
|
2021
Q2 | $3.66M | Sell |
181,665
-57,672
| -24% | -$1.09M | 0.01% | 1170 |
|
|
2021
Q1 | $4.38M | Sell |
239,337
-49,578
| -17% | -$922K | 0.01% | 1081 |
|
|
2020
Q4 | $5.81M | Buy |
288,915
+60,640
| +27% | +$1.18M | 0.01% | 940 |
|
|
2020
Q3 | $4.28M | Buy |
228,275
+79,860
| +54% | +$1.61M | 0.01% | 992 |
|
|
2020
Q2 | $3.33M | Buy |
148,415
+94,325
| +174% | +$1.73M | 0.01% | 1126 |
|
|
2020
Q1 | $803K | Sell |
54,090
-4,143
| -7% | -$72.1K | ﹤0.01% | 1766 |
|
|
2019
Q4 | $1.12M | Sell |
58,233
-4,537
| -7% | -$87K | ﹤0.01% | 1820 |
|
|
2019
Q3 | $1.25M | Sell |
62,770
-306
| -0.5% | -$6.37K | ﹤0.01% | 1761 |
|
|
2019
Q2 | $1.33M | Buy |
63,076
+870
| +1% | +$18.2K | ﹤0.01% | 1774 |
|
|
2019
Q1 | $1.27M | Buy |
62,206
+211
| +0.3% | +$4.73K | ﹤0.01% | 1790 |
|
|
2018
Q4 | $1.23M | Buy |
61,995
+5,085
| +9% | +$100K | ﹤0.01% | 1733 |
|
|
2018
Q3 | $1.09M | Sell |
56,910
-2,270
| -4% | -$40.5K | ﹤0.01% | 1848 |
|
|
2018
Q2 | $903K | Sell |
59,180
-3,200
| -5% | -$55.9K | ﹤0.01% | 1927 |
|
|
2018
Q1 | $1.17M | Buy |
62,380
+4,850
| +8% | +$91.2K | ﹤0.01% | 1810 |
|
|
2017
Q4 | $1.11M | Sell |
57,530
-6,050
| -10% | -$113K | ﹤0.01% | 1815 |
|
|
2017
Q3 | $1.14M | Buy |
63,580
+4,850
| +8% | +$79.8K | ﹤0.01% | 1801 |
|
|
2017
Q2 | $1.05M | Sell |
58,730
-29,940
| -34% | -$475K | ﹤0.01% | 1823 |
|
|
2017
Q1 | $1.29M | Sell |
88,670
-261,600
| -75% | -$4.11M | ﹤0.01% | 1763 |
|
|
2016
Q4 | $6.45M | Sell |
350,270
-45,530
| -12% | -$886K | 0.01% | 1009 |
|
|
2016
Q3 | $7.51M | Buy |
+395,800
| New | +$7.18M | 0.01% | 932 |
|
Other funds holding AMPH
VCM
BTW
Prudential Financial's AMPH Position: Q1 2026 in Review
Prudential Financial increased its Amphastar Pharmaceuticals (AMPH) stake by 7.4% in Q1 2026, buying an estimated $85.4K and bringing the position to 50,693 shares worth $993K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.
Prudential Financial first reported a position in AMPH in Q3 2016 and has held it in 39 quarters since. The position peaked at $7.51M in Q3 2016. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Prudential Financial held 50,693 shares of Amphastar Pharmaceuticals worth $993K as of Q1 2026.
- Prudential Financial bought 3,490 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $85.4K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1604 holding.
- Prudential Financial first reported a position in Amphastar Pharmaceuticals in Q3 2016 and has held it in 39 quarters since.
- Prudential Financial's Amphastar Pharmaceuticals position peaked at $7.51M in Q3 2016.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.